Xenadrine Marketer Settles With N.J.; Owner Faces New Suit With FTC

FTC announced action against Cytodyne Technologies owner Robert Chinery July 13. The complaint was filed two days after the firm's settlement of false advertising charges exempted Chinery from certain advertising constraints